Literature DB >> 19697099

Stable mixed donor-donor chimerism after double cord blood transplantation.

Sofia Berglund1,2, Mantas Okas1,2, Jens Gertow2, Michael Uhlin2, Jonas Mattsson3,4.   

Abstract

Double cord blood transplantation (DCBT) has been used increasingly and has proven to be both safe and efficacious. In chimerism analysis, previous studies have indicated single unit predominance early after DCBT. In the present study, we evaluated the chimeric pattern in T-, B- and myeloid cells using PCR-based chimerism analysis in seven patients after DCBT: five patients had acute leukemia and two had lymphoma. Five patients received myeloablative conditioning and two patients were given reduced intensity conditioning. All patients received anti-thymocyte globulin (ATG) before DCBT. Three of the six evaluable patients showed donor-donor mixed chimerism in all cell lineages at 90 days after DCBT. Interestingly, two patients in long-term follow-up showed mixed donor chimerism in all cell lineages at 25 and 35 months after DCBT, respectively. Both patients are doing clinically well. Neither of the two developed GVHD after DCBT. In conclusion, in this study donor-donor mixed chimerism was common after high dose ATG and DCBT. Further studies are warranted concerning the immunological consequences of the phenomenon of donor-donor mixed chimerism after DCBT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19697099     DOI: 10.1007/s12185-009-0398-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  27 in total

1.  Early engraftment kinetics of two units cord blood transplantation.

Authors:  H J Kang; S H Kho; M K Jang; S H Lee; H Y Shin; H S Ahn
Journal:  Bone Marrow Transplant       Date:  2006-06-19       Impact factor: 5.483

2.  Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.

Authors:  R L Haspel; G Kao; B Y Yeap; C Cutler; R J Soiffer; E P Alyea; V T Ho; J Koreth; B R Dey; S L McAfee; E C Attar; T Spitzer; J H Antin; K K Ballen
Journal:  Bone Marrow Transplant       Date:  2007-11-26       Impact factor: 5.483

3.  Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose.

Authors:  M Remberger; J Mattsson; B-M Svahn; O Ringdén
Journal:  Bone Marrow Transplant       Date:  2008-08-11       Impact factor: 5.483

4.  T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation.

Authors:  J Mattsson; M Uzunel; M Remberger; O Ringdén
Journal:  Transplantation       Date:  2001-02-15       Impact factor: 4.939

5.  Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).

Authors:  S T Ildstad; S M Wren; J A Bluestone; S A Barbieri; D Stephany; D H Sachs
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

6.  Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.

Authors:  Mehmet Uzunel; Mats Remberger; Darius Sairafi; Zuzana Hassan; Jonas Mattsson; Brigitta Omazic; Lisbeth Barkholt; Olle Ringdén
Journal:  Transplantation       Date:  2006-10-15       Impact factor: 4.939

Review 7.  Expanding the role of umbilical cord blood transplantation.

Authors:  Claudio G Brunstein; Daniela C Setubal; John E Wagner
Journal:  Br J Haematol       Date:  2007-04       Impact factor: 6.998

8.  Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.

Authors:  J N Barker; S M Davies; T DeFor; N K Ramsay; D J Weisdorf; J E Wagner
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

9.  Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation.

Authors:  Mats Remberger; Britt-Marie Svahn; Jonas Mattsson; Olle Ringdén
Journal:  Transplantation       Date:  2004-07-15       Impact factor: 4.939

10.  Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.

Authors:  Britt-Marie Svahn; Mats Remberger; Karl-Erik Myrbäck; Katarina Holmberg; Britta Eriksson; Patrik Hentschke; Johan Aschan; Lisbeth Barkholt; Olle Ringdén
Journal:  Blood       Date:  2002-08-22       Impact factor: 22.113

View more
  6 in total

1.  Stable mixed double donor chimerism: Absence of war doesn't necessarily mean peace.

Authors:  Jens Gertow; Jonas Mattsson J; Michael Uhlin
Journal:  Chimerism       Date:  2010-10

2.  Chimerism and use of mesenchymal stem cells in umbilical cord blood transplantation.

Authors:  Sofia Berglund; Michael Uhlin; Jonas Mattsson
Journal:  Chimerism       Date:  2013-01-01

3.  Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation.

Authors:  J Gertow; S Berglund; M Okas; M Uzunel; L Berg; K Kärre; J Mattsson; M Uhlin
Journal:  Clin Exp Immunol       Date:  2010-08-20       Impact factor: 4.330

Review 4.  An overview of the progress on double umbilical cord blood transplantation.

Authors:  Anastasia Sideri; Nikolaos Neokleous; Philippe Brunet De La Grange; Bernadette Guerton; Marie-Caroline Le Bousse Kerdilles; Georges Uzan; Corina Peste-Tsilimidos; Eliane Gluckman
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

5.  Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.

Authors:  Judith A E Somers; Eric Braakman; Bronno van der Holt; Eefke J Petersen; Erik W A Marijt; Cynthia Huisman; Kees Sintnicolaas; Machteld Oudshoorn; Marlies E Groenendijk-Sijnke; Anneke Brand; Jan J Cornelissen
Journal:  Haematologica       Date:  2014-08-08       Impact factor: 9.941

6.  Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?

Authors:  Arwen Stikvoort; Mikael Sundin; Mehmet Uzunel; Jens Gertow; Berit Sundberg; Marie Schaffer; Jonas Mattsson; Michael Uhlin
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.